Omeros stock rocketed to a five-year high Thursday on blowout second-quarter results for its new treatment for transplant complications. The post This Biotech Stock Just Gapped Up To A Five-Year High; Here's Why appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real